Mind Medicine (MindMed) Inc
NASDAQ:MNMD

Watchlist Manager
Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Watchlist
Price: 7.56 USD 6.63% Market Closed
Market Cap: 554.4m USD
Have any thoughts about
Mind Medicine (MindMed) Inc?
Write Note

Mind Medicine (MindMed) Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mind Medicine (MindMed) Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Cash from Operating Activities
-$74.3m
CAGR 3-Years
-18%
CAGR 5-Years
-223%
CAGR 10-Years
-94%
Bausch Health Companies Inc
TSX:BHC
Cash from Operating Activities
$1.4B
CAGR 3-Years
-8%
CAGR 5-Years
-3%
CAGR 10-Years
-2%
Sundial Growers Inc
NASDAQ:SNDL
Cash from Operating Activities
-CA$16.6m
CAGR 3-Years
34%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Cash from Operating Activities
$16.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Cash from Operating Activities
CA$52.8m
CAGR 3-Years
6%
CAGR 5-Years
174%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Cash from Operating Activities
$56.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Mind Medicine (MindMed) Inc
Glance View

Market Cap
554.4m USD
Industry
Pharmaceuticals

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.

MNMD Intrinsic Value
3.7 USD
Overvaluation 51%
Intrinsic Value
Price

See Also

What is Mind Medicine (MindMed) Inc's Cash from Operating Activities?
Cash from Operating Activities
-74.3m USD

Based on the financial report for Sep 30, 2024, Mind Medicine (MindMed) Inc's Cash from Operating Activities amounts to -74.3m USD.

What is Mind Medicine (MindMed) Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-94%

Over the last year, the Cash from Operating Activities growth was -31%. The average annual Cash from Operating Activities growth rates for Mind Medicine (MindMed) Inc have been -18% over the past three years , -223% over the past five years , and -94% over the past ten years .

Back to Top